Maarten Van Roy

Animal models in translational medicine: Validation and prediction

Tinneke Denayer, Thomas Stöhr, Maarten Van Roy · European Journal of Molecular & Clinical Medicine · 2014 · 446 citations

Medicine, Pharmacology, Translational Sciences +16

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

Maarten Van Roy, Cedric Ververken, Els Beirnaert et al. · Arthritis Research & Therapy · 2015 · 179 citations · Full text

Medicine, Immunology, Pharmacology +14

Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo

David Maussang, Azra Mujić-Delić, Francis J. Descamps et al. · Journal of Biological Chemistry · 2013 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium

Filip Van Hauwermeiren, Marietta Armaka, Niki Karagianni et al. · Journal of Clinical Investigation · 2013 · 80 citations · Full text

Life Sciences, Immunology, Oncology +17

Reperfusion of cerebral artery thrombosis by the GPIb–VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs

Stefania Momi, Michela Tantucci, Maarten Van Roy et al. · Blood · 2013 · 69 citations · Full text

Medicine, Cardiology, Pharmacology +12